Carlson G L, Li B U, Bass P, Olsen W A
Science. 1983 Jan 28;219(4583):393-5. doi: 10.1126/science.6184780.
A commercial alpha-amylase inhibitor with potent inhibitory activity in vitro was used in a randomized double-blind, cross-over clinical trial in six nonobese, healthy adult males. In these subjects, this inhibitor had no effect on the response of blood glucose, insulin, or breath hydrogen to a standardized starch meal. It is concluded that this formulation has no effect on starch digestion in humans.
一种在体外具有强大抑制活性的商业α-淀粉酶抑制剂，被用于一项针对6名非肥胖健康成年男性的随机双盲交叉临床试验。在这些受试者中，该抑制剂对标准化淀粉餐引起的血糖、胰岛素或呼气氢反应没有影响。得出的结论是，该制剂对人类淀粉消化没有影响。
